Fridolin Hefti
Impact in
-
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies
- Heart Failure Treatment and Management
-
- Hormonal Regulation and Hypertension
Papers in
-
- Receptor Mechanisms and Signaling 4
- Pharmacological Receptor Mechanisms and Effects 1
-
- Renin-Angiotensin System Studies 4
- Blood Pressure and Hypertension Studies 2
- Co-authors
- Herbert Kühn (4 shared papers)Jerry S. Powell (3 shared papers)Hans R. Baumgartner (3 shared papers)Rita Müller (3 shared papers)Markus Hosang (1 shared paper)Jean‐Paul Clozel (3 shared papers)Herwig Eggers (1 shared paper)Horst A. Welker (1 shared paper)
- Journals
- Journal of Cardiovascular Pharmacology (3 papers)Drugs (1 paper)The American Journal of Medicine (1 paper)Cardiovascular Drug Reviews (1 paper)Science (1 paper)
- Partner nations
- SwitzerlandAustria
In The Last Decade
Fridolin Hefti
8 papers receiving 1.1k citations
Fridolin Hefti's Hit Papers
Peers
Comparison fields: 5 of 83
- Cardiology and Cardiovascular Medicine 738
- Endocrinology, Diabetes and Metabolism 275
- Genetics 82
- Surgery 299
- Immunology and Allergy 40
Countries citing papers authored by Fridolin Hefti
This map shows the geographic impact of Fridolin Hefti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fridolin Hefti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fridolin Hefti more than expected).
Fields of papers citing papers by Fridolin Hefti
This network shows the impact of papers produced by Fridolin Hefti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fridolin Hefti. The network helps show where Fridolin Hefti may publish in the future.
Co-authors
The 13 scholars most cited alongside Fridolin Hefti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury Hit paper breakdown → | 1989 | 893 |
| 2 | 1990 | 101 | |
| 3 | 1991 | 92 | |
| 4 | 1989 | 42 | |
| 5 | 1988 | 25 | |
| 6 | 1988 | 18 | |
| 7 | 1987 | 9 | |
| 8 | 1991 | 4 |
About Fridolin Hefti
Fridolin Hefti is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (4 papers), Receptor Mechanisms and Signaling (4 papers), Blood Pressure and Hypertension Studies (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Hormonal Regulation and Hypertension (2 papers), Pharmacological Receptor Mechanisms and Effects (1 paper), Oral and gingival health research (1 paper) and Pharmacological Effects and Toxicity Studies (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (738 citations), Endocrinology, Diabetes and Metabolism (275 citations), Genetics (82 citations), Surgery (299 citations) and Immunology and Allergy (40 citations). Fridolin Hefti has collaborated with scholars based in Switzerland and Austria. Frequent co-authors include Herbert Kühn, Jerry S. Powell, Hans R. Baumgartner, Rita Müller, Markus Hosang, Jean‐Paul Clozel, Herwig Eggers, Horst A. Welker, Wolfgang Osterrieder and Rita Schmitt. Their work appears in journals such as Journal of Cardiovascular Pharmacology, Drugs, The American Journal of Medicine, Cardiovascular Drug Reviews and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.